Distribution of colorectal polyps: Implications for screening

Best Practice and Research: Clinical Gastroenterology

Volumn 31, Issue 4, 2017, Pages 481-488

  Senore, Carlo ^a   Bellisario, Cristina ^a   Segnan, Nereo ^a  

^a CITTÀ DELLA SALUTE E DELLA SCIENZA HOSPITAL   (Italy)

Author keywords

Colonoscopy; Colorectal adenomas; FIT; Proximal colon; Screening; Sigmoidoscopy

Indexed keywords

ANATOMICAL VARIATION; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL POLYP; CROSS-SECTIONAL STUDY; HUMAN; META ANALYSIS; OBSERVATIONAL STUDY; PREVALENCE; RECTUM ADENOMA; REVIEW; SCREENING TEST; SYSTEMATIC REVIEW; TUMOR LOCALIZATION; COLON POLYP; COLORECTAL TUMOR; DIAGNOSTIC IMAGING; EARLY CANCER DIAGNOSIS; FEMALE; MALE; PATHOLOGY; PROCEDURES;

COLONIC POLYPS; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MALE;

EID: 85018969218     PISSN: 15216918     EISSN: 15321916     Source Type: Journal    
DOI: 10.1016/j.bpg.2017.04.008     Document Type: Review

References (81)

1. Pino, M.S., Chung, D.C., The chromosomal instability pathway in colon cancer. Gastroenterology 138 (2010), 2059–2072.
2. Leggett, B., Whitehall, V., Role of the serrated pathway in colorectal cancer pathogenesis. Gastroenterology 138 (2010), 2088–2100.
3. Atkin, W., Options for screening for colorectal cancer. Scand J Gastroenterol Suppl, 2003, 13–16.
4. Atkin, W.S., Edwards, R., Kralj-Hans, I., Wooldrage, K., Hart, A.R., Northover, J.M., et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 375 (2010), 1624–1633.
5. Segnan, N., Armaroli, P., Bonelli, L., Risio, M., Sciallero, S., Zappa, M., et al. Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial–SCORE. J Natl Cancer Inst 103 (2011), 1310–1322.
6. Holme, O., Loberg, M., Kalager, M., Bretthauer, M., Hernan, M.A., Aas, E., et al. Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial. JAMA 312 (2014), 606–615.
7. Schoen, R.E., Pinsky, P.F., Weissfeld, J.L., Yokochi, L.A., Church, T., Laiyemo, A.O., et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med 366 (2012), 2345–2357.
8. Mandel, J.S., Church, T.R., Bond, J.H., Ederer, F., Geisser, M.S., Mongin, S.J., et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 343 (2000), 1603–1607.
9. Ventura, L., Mantellini, P., Grazzini, G., Castiglione, G., Buzzoni, C., Rubeca, T., et al. The impact of immunochemical faecal occult blood testing on colorectal cancer incidence. Dig Liver Dis 46 (2014), 82–86.
10. Cooper, G.S., Yuan, Z., Landefeld, C.S., Johanson, J.F., Rimm, A.A., A national population-based study of incidence of colorectal cancer and age. Implications for screening in older Americans. Cancer 75 (1995), 775–781.
11. Cucino, C., Buchner, A.M., Sonnenberg, A., Continued rightward shift of colorectal cancer. Dis Colon Rectum 45 (2002), 1035–1040.
12. McCallion, K., Mitchell, R.M., Wilson, R.H., Kee, F., Watson, R.G., Collins, J.S., et al. Flexible sigmoidoscopy and the changing distribution of colorectal cancer: implications for screening. Gut 48 (2001), 522–525.
13. Rabeneck, L., Davila, J.A., El-Serag, H.B., Is there a true “shift” to the right colon in the incidence of colorectal cancer?. Am J Gastroenterol 98 (2003), 1400–1409.
14. Ponz de Leon, M., Marino, M., Benatti, P., Rossi, G., Menigatti, M., Pedroni, M., et al. Trend of incidence, subsite distribution and staging of colorectal neoplasms in the 15-year experience of a specialised cancer registry. Ann Oncol 15 (2004), 940–946.
15. Cheng, L., Eng, C., Nieman, L.Z., Kapadia, A.S., Du, X.L., Trends in colorectal cancer incidence by anatomic site and disease stage in the United States from 1976 to 2005. Am J Clin Oncol 34 (2011), 573–580.
16. Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 8 (2010), 336–341.
17. Segnan, N.P.J., von Karsa, L., (eds.) European guidelines for quality assurance in colorectal cancer screening and diagnosis – first edition, 2010, Publications Office of the European Union. European Commision, Luxembourg.
18. Ponti, A., Anttila, A., Ronco, G., Senore, C., Basu, P., Segnan, N., et al. Cancer screening in the European union. 2017, International Agency for Research on Cancer Lyon, France.
19. Chablani, S.V., Jandorf, L., DuHamel, K., Lee, K.K., Sriphanlop, P., Villagra, C., et al. Adenoma prevalence and distribution among US Latino subgroups undergoing screening colonoscopy. Dig Dis Sci, 2016 PMID: 27913995.
20. Ashktorab, H., Laiyemo, A.O., Lee, E., Cruz-Correa, M., Ghuman, A., Nouraie, M., et al. Prevalence and features of colorectal lesions among Hispanics: a hospital-based study. World J Gastroenterol 21 (2015), 13095–13100.
21. Shaib, Y.H., Rabaa, E., Qaseem, T., The site distribution and characteristics of colorectal adenomas in hispanics: a comparative study. Am J Gastroenterol 97 (2002), 2100–2102.
22. Lee, B., Holub, J., Peters, D., Lieberman, D., Prevalence of colon polyps detected by colonoscopy screening of asymptomatic Hispanic patients. Dig Dis Sci 57 (2012), 481–488.
23. Laird-Fick, H.S., Chahal, G., Olomu, A., Gardiner, J., Richard, J., Dimitrov, N., Colonic polyp histopathology and location in a community-based sample of older adults. BMC Gastroenterol, 16, 2016, 90.
24. Jackson, C.S., Vega, K.J., Higher prevalence of proximal colon polyps and villous histology in African-Americans undergoing colonoscopy at a single equal access center. J Gastrointest Oncol 6 (2015), 638–643.
25. Velayos Jimenez, B., Duran Rigueira, M., Arevalo Serna, J.A., Heras Martin, I., Bernal Martinez, A., Pons Renedo, F., et al. Distribution of polyps in the inside region of Vizcaya (Spain): implications for diagnostic tests and colorectal cancer screening. Gastroenterol Hepatol 26 (2003), 401–406.
26. Patel, K., Hoffman, N.E., The anatomical distribution of colorectal polyps at colonoscopy. J Clin Gastroenterol 33 (2001), 222–225.
27. Cai, B., Liu, Z., Yansong, X., Wei, W., Zhang, S., Adenoma detection rate in 41,010 patients from Southwest China. Oncol Lett 9 (2015), 2073–2077.
28. Hodadoostan, M.K., Reza, F., Elham, M., Mohammad Alizade, A.H., Molaie, M., Mashaiekhy, R., et al. Clinical and pathology characteristics of colorectal polyps in Iranian population. Asian Pac J Cancer Prev 11 (2010), 557–560.
29. Hemmasi, G., Sohrabi, M., Zamani, F., Ajdarkosh, H., Rakhshani, N., Khoonsari, M., et al. Prevalence of colorectal adenoma in an average-risk population aged 40–50 versus 50–60 years. Eur J Cancer Prev 24 (2015), 386–390.
30. Cha, J.M., Kozarek, R.A., La Selva, D., Gluck, M., Ross, A., Chiorean, M., et al. Disparities in prevalence, location, and shape characteristics of colorectal neoplasia between South Korean and U.S. patients. Gastrointest Endosc 82 (2015), 1080–1086.
31. Kahi, C.J., Hewett, D.G., Norton, D.L., Eckert, G.J., Rex, D.K., Prevalence and variable detection of proximal colon serrated polyps during screening colonoscopy. Clin Gastroenterol Hepatol 9 (2011), 42–46.
32. McCashland, T.M., Brand, R., Lyden, E., De Garmo, P., Gender differences in colorectal polyps and tumors. Am J Gastroenterol 96 (2001), 882–886.
33. de Oliveira, A.M., Anapaz, V., Lourenco, L., Graca Rodrigues, C., Folgado Alberto, S., Martins, A., et al. Is there a proximal shift in the distribution of colorectal adenomas?. United Eur Gastroenterol J 3 (2015), 353–357.
34. Visovan, I.I., Tantau, M., Ciobanu, L., Pascu, O., Tantau, A., Increasing prevalence of right-sided colonic adenomas in a high-volume endoscopy department in Romania: implications for colorectal cancer screening. J Gastrointest Liver Dis 23 (2014), 147–151.
35. Fenoglio, L., Castagna, E., Comino, A., Luchino, C., Senore, C., Migliore, E., et al. A shift from distal to proximal neoplasia in the colon: a decade of polyps and CRC in Italy. BMC Gastroenterol, 10, 2010, 139.
36. Kiedrowski, M., Mroz, A., Kaminski, M.F., Kraszewska, E., Orlowska, J., Olszewski, W., et al. Proximal shift of advanced adenomas in the large bowel–does it really exist?. Pol Arch Med Wewn 122 (2012), 195–199.
37. Bai, Y., Gao, J., Zou, D.-W., Li, Z.-S., Distribution trends of colorectal adenoma and cancer: a colonoscopy database analysis of 11,025 Chinese patients. J Gastroenterol Hepatol 25 (2010), 1668–1673.
38. Gill, P., Rafferty, H., Munday, D., Bailey, A., Wang, L.M., East, J.E., et al. Proximal colon cancer and serrated adenomas – hunting the missing 10%. Clin Med (Lond) 13 (2013), 557–561.
39. Hetzel, J.T., Huang, C.S., Coukos, J.A., Omstead, K., Cerda, S.R., Yang, S., et al. Variation in the detection of serrated polyps in an average risk colorectal cancer screening cohort. Am J Gastroenterol 105 (2010), 2656–2664.
40. Brenner, H., Hoffmeister, M., Arndt, V., Stegmaier, C., Altenhofen, L., Haug, U., Protection from right-and left-sided colorectal neoplasms after colonoscopy: population-based study. J Natl Cancer Inst 102 (2010), 89–95.
41. Lakoff, J., Paszat, L.F., Saskin, R., Rabeneck, L., Risk of developing proximal versus distal colorectal cancer after a negative colonoscopy: a population-based study. Clin Gastroenterol Hepatol 6 (2008), 1117–1121 quiz 064.
42. Nishihara, R., Wu, K., Lochhead, P., Morikawa, T., Liao, X., Qian, Z.R., et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. New Engl J Med 369 (2013), 1095–1105.
43. Brenner, H., Chang-Claude, J., Seiler, C.M., Hoffmeister, M., Long-term risk of colorectal cancer after negative colonoscopy. J Clin Oncol 29 (2011), 3761–3767.
44. Singh, S., Singh, P.P., Murad, M.H., Singh, H., Samadder, N.J., Prevalence, risk factors, and outcomes of interval colorectal cancers: a systematic review and meta-analysis. Am J Gastroenterol 109 (2014), 1375–1389.
45. Arain, M.A., Sawhney, M., Sheikh, S., Anway, R., Thyagarajan, B., Bond, J.H., et al. CIMP status of interval colon cancers: another piece to the puzzle. Am J Gastroenterol 105 (2010), 1189–1195.
46. Hirai, H.W., Tsoi, K.K., Chan, J.Y., Wong, S.H., Ching, J.Y., Wong, M.C., et al. Systematic review with meta-analysis: faecal occult blood tests show lower colorectal cancer detection rates in the proximal colon in colonoscopy-verified diagnostic studies. Aliment Pharmacol Ther 43 (2016), 755–764.
47. Haug, U., Knudsen, A.B., Brenner, H., Kuntz, K.M., Is fecal occult blood testing more sensitive for left- versus right-sided colorectal neoplasia? A systematic literature review. Expert Rev Mol Diagn 11 (2011), 605–616.
48. Brenner, H., Niedermaier, T., Chen, H., Strong subsite-specific variation in detecting advanced adenomas by fecal immunochemical testing for hemoglobin. Int J Cancer 140 (2017), 2015–2022.
49. de Wijkerslooth, T.R., Stoop, E.M., Bossuyt, P.M., Meijer, G.A., van Ballegooijen, M., van Roon, A.H., et al. Immunochemical fecal occult blood testing is equally sensitive for proximal and distal advanced neoplasia. Am J Gastroenterol 107 (2012), 1570–1578.
50. Kim, N.H., Yang, H.J., Park, S.K., Park, J.H., Park, D.I., Sohn, C.I., et al. Does low threshold value use improve proximal neoplasia detection by fecal immunochemical test?. Dig Dis Sci 61 (2016), 2685–2693.
51. Wong, M.C., Ching, J.Y., Chan, V.C., Lam, T.Y., Shum, J.P., Luk, A.K., et al. Diagnostic accuracy of a qualitative fecal immunochemical test varies with location of neoplasia but not number of specimens. Clin Gastroenterol Hepatol 13 (2015), 1472–1479.
52. IJspeert, J.E., Bevan, R., Senore, C., Kaminski, M.F., Kuipers, E.J., Mroz, A., et al. Detection rate of serrated polyps and serrated polyposis syndrome in colorectal cancer screening cohorts: a European overview. Gut, 2016 PMID: 26911398.
53. O'Connell, B.M., Crockett, S.D., The clinical impact of serrated colorectal polyps. Clin Epidemiol 9 (2017), 113–125.
54. Giorgi Rossi, P., Carretta, E., Mangone, L., Baracco, S., Serraino, D., Zorzi, M., Incidence of interval cancers in faecal immunochemical test colorectal screening programmes in Italy. J Med Screen, 2017 PMID: 28195508 969141316686391.
55. Castells, A., Bessa, X., Quintero, E., Bujanda, L., Cubiella, J., Salas, D., et al. Risk of advanced proximal neoplasms according to distal colorectal findings: comparison of sigmoidoscopy-based strategies. J Natl Cancer Inst 105 (2013), 878–886.
56. Castells, A., Quintero, E., Alvarez, C., Bujanda, L., Cubiella, J., Salas, D., et al. Rate of detection of advanced neoplasms in proximal colon by simulated sigmoidoscopy vs fecal immunochemical tests. Clin Gastroenterol Hepatol, 12, 2014 1708–16.e4.
57. Castro, I., Estevez, P., Cubiella, J., Hernandez, V., Gonzalez-Mao, C., Rivera, C., et al. Diagnostic performance of fecal immunochemical test and sigmoidoscopy for advanced right-sided colorectal neoplasms. Dig Dis Sci 60 (2015), 1424–1432.
58. Joo, S.K., Kim, J.W., Lee, K.L., Kim, B.G., Jeong, J.B., Lee, J.K., et al. The incidence and clinical characteristics of proximal colonic polyps when the polyps are noted on rectosigmoid colon by colonoscopy. Korean J Gastroenterol 62 (2013), 42–48.
59. Lucendo, A.J., Guagnozzi, D., Angueira, T., Gonz+ílez-Castillo, S., Fern+índez-Fuente, M., Friginal-Ruiz, A.B., et al. The relationship between proximal and distal colonic adenomas: is screening sigmoidoscopy enough in the presence of a changing epidemiology?. Eur J Gastroenterol Hepatol 25 (2013), 973–980.
60. Nicholson, F.B., Korman, M.G., Stern, A.I., Hansky, J., Distribution of colorectal adenomas: implications for bowel cancer screening. Med J Aust 172 (2000), 428–430.
61. Betes Ibanez, M., Munoz-Navas, M.A., Duque, J.M., Angos, R., Macias, E., Subtil, J.C., et al. Diagnostic value of distal colonic polyps for prediction of advanced proximal neoplasia in an average-risk population undergoing screening colonoscopy. Gastrointest Endosc 59 (2004), 634–641.
62. Schoenfeld, P., Cash, B., Flood, A., Dobhan, R., Eastone, J., Coyle, W., et al. Colonoscopic screening of average-risk women for colorectal neoplasia. New Engl J Med 352 (2005), 2061–2068.
63. Imperiale, T.F., Glowinski, E.A., Lin-Cooper, C., Ransohoff, D.F., Tailoring colorectal cancer screening by considering risk of advanced proximal neoplasia. Am J Med 125 (2012), 1181–1187.
64. Kahi, C.J., Vemulapalli, K.C., Snover, D.C., Abdel Jawad, K.H., Cummings, O.W., Rex, D.K., Findings in the distal colorectum are not associated with proximal advanced serrated lesions. Clin Gastroenterol Hepatol 13 (2015), 345–351.
65. Holme, O., Schoen, R.E., Senore, C., Segnan, N., Hoff, G., Løberg, M., et al. Effectiveness of flexible sigmoidoscopy screening in men and women and different age groups: pooled analysis of randomised trials. BMJ, 2017, 356.
66. Gupta, S., Balasubramanian, B.A., Fu, T., Genta, R.M., Rockey, D.C., Lash, R., Polyps with advanced neoplasia are smaller in the right than in the left colon: implications for colorectal cancer screening. Clin Gastroenterol Hepatol, 10, 2012 1395–401.e2.
67. Meza, R., Jeon, J., Renehan, A.G., Luebeck, E.G., Colorectal cancer incidence trends in the United States and United Kingdom: evidence of right- to left-sided biological gradients with implications for screening. Cancer Res 70 (2010), 5419–5429.
68. Hundt, S., Haug, U., Brenner, H., Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection. Ann Intern Med 150 (2009), 162–169.
69. Corleto, V.D., Pagnini, C., Cattaruzza, M.S., Zykaj, E., Di Giulio, E., Margagnoni, G., et al. Is proliferative colonic disease presentation changing?. World J Gastroenterol 18 (2012), 6614–6619.
70. Park, S.Y., Kim, B.C., Shin, S.J., Lee, S.K., Kim, T.I., Kim, W.H., Proximal shift in the distribution of adenomatous polyps in Korea over the past ten years. Hepatogastroenterology 56 (2009), 677–681.
71. Jspeert, J., Vermeulen, L., Meijer, G.A., Dekker, E., Serrated neoplasia-role in colorectal carcinogenesis and clinical implications. Nat Rev Gastroenterol Hepatol 12 (2015), 401–409.
72. Jspeert, J., de Wit, K., van der Vlugt, M., Bastiaansen, B.A., Fockens, P., Dekker, E., Prevalence, distribution and risk of sessile serrated adenomas/polyps at a center with a high adenoma detection rate and experienced pathologists. Endoscopy 48 (2016), 740–746.
73. Baxter, N.N., Goldwasser, M.A., Paszat, L.F., Saskin, R., Urbach, D.R., Rabeneck, L., Association of colonoscopy and death from colorectal cancer. Ann Intern Med 150 (2009), 1–8.
74. Singh, H., Nugent, Z., Demers, A.A., Kliewer, E.V., Mahmud, S.M., Bernstein, C.N., The reduction in colorectal cancer mortality after colonoscopy varies by site of the cancer. Gastroenterology 139 (2010), 1128–1137.
75. Zorzi, M., Fedato, C., Grazzini, G., Stocco, F.C., Banovich, F., Bortoli, A., et al. High sensitivity of five colorectal screening programmes with faecal immunochemical test in the Veneto Region, Italy. Gut 60 (2011), 944–949.
76. Segnan, N., Senore, C., Andreoni, B., Azzoni, A., Bisanti, L., Cardelli, A., et al. Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening. Gastroenterology 132 (2007), 2304–2312.
77. Atkin, W., Wooldrage, K., Parkin, D.M., Kralj-Hans, I., MacRae, E., Shah, U., et al. Long term effects of once-only flexible sigmoidoscopy screening after 17 years of follow-up: the UK flexible sigmoidoscopy screening randomised controlled trial. Lancet, 2017 PMID: 28236467.
78. Brenner, H., Altenhofen, L., Kretschmann, J., Rosch, T., Pox, C., Stock, C., et al. Trends in adenoma detection rates during the first 10 years of the German screening colonoscopy program. Gastroenterology, 149, 2015 356–66.e1.
79. Gavin, D.R., Valori, R.M., Anderson, J.T., Donnelly, M.T., Williams, J.G., Swarbrick, E.T., The national colonoscopy audit: a nationwide assessment of the quality and safety of colonoscopy in the UK. Gut 62 (2013), 242–249.
80. Imperiali, G., Minoli, G., Meucci, G.M., Spinzi, G., Strocchi, E., Terruzzi, V., et al. Effectiveness of a continuous quality improvement program on colonoscopy practice. Endoscopy 39 (2007), 314–318.
81. Tinmouth, J., Henry, P., Hsieh, E., Baxter, N.N., Hilsden, R.J., Elizabeth McGregor, S., et al. Sessile serrated polyps at screening colonoscopy: have they been under diagnosed?. Am J Gastroenterol 109 (2014), 1698–1704.